Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
Saved in:
| Title: | Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease. |
|---|---|
| Authors: | Ruben CL; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Pirsl F; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 2W334, Bethesda, MD, 20850, USA., Holtzman NG; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Parsons-Wandell L; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Baruffaldi J; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Curtis LM; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Mitchell SA; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive MSC 9764, Bethesda, MD, 20892, USA., Kerep AZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA., Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 12N240A, Bethesda, MD, 20892, USA., Berger A; Pain and Palliative Care Service, National Institutes of Health Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD, 20892, USA., Joe GO; Rehabilitation Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD, 20892, USA., Datiles MB 3rd; National Eye Institute, National Institutes of Health, 31 Center Drive, Building 31, MSC 2510, Bethesda, MD, 20892, USA., Mays JW; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Building 30 Room 301, MSC 4340, Bethesda, MD, 20892, USA., Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room CRC 4-3130, Bethesda, MD, 20892, USA. pavletis@mail.nih.gov. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2021 Jul; Vol. 56 (7), pp. 1584-1592. Date of Electronic Publication: 2021 Feb 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
